FDA Panel To Review Pfizer Vaccine For Children

FDA Panel To Review Pfizer Vaccine For Children

Newsy

Published

Watch VideoYour kids could be one step closer to getting vaccinated. An FDA panel is meeting Tuesday to consider Pfizer's COVID vaccine for kids ages 5 to 11. 

Data from Pfizer shows a shot is more than 90% effective against symptomatic disease — not just hospitalization and death — for kids in that age range. 

The...

Full Article